Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders. It is caused by mutations in the NF1 gene which comprises 60 exons and is located on chromosome 17q. The NF1 gene product, neurofibromin, displays partial homology to GTPase-activating protein (GAP). The GAP-related domain (GRD), encoded by exons 20-27a, is the only region of neurofibromin to which a biological function has been ascribed. A total of 320 unrelated NF1 patients were screened for mutations in the GRD-encoding region of the NF1 gene. Sixteen different lesions in the NF1 GRD region were identified in a total of 20 patients. Of these lesions, 14 are novel and together comprise three missense, two nonsense and three splice site mutations plus si...
Neurofibromatosis type-1 (NF1) is caused by constitutional mutations of the NF1 tumor-suppressor g...
Neurofibromatosis type-1 (NF1) is caused by constitutional mutations of the NF1 tumor-suppressor g...
More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in ...
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders. It is caused ...
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders. It is caused ...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder caused by mutations in the NF...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder caused by mutations in the NF...
Neurofibromatosis type 1 (NF 1 ) is one of dm most common autosomal dominant conditions in humans (...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder caused by mutations in the NF...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder caused by mutations in the NF...
Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis o...
Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis o...
More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in ...
Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis o...
Neurofibromatosis type 1 (NF1) is a common familial tumour syndrome with multiple clinical features ...
Neurofibromatosis type-1 (NF1) is caused by constitutional mutations of the NF1 tumor-suppressor g...
Neurofibromatosis type-1 (NF1) is caused by constitutional mutations of the NF1 tumor-suppressor g...
More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in ...
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders. It is caused ...
Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders. It is caused ...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder caused by mutations in the NF...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder caused by mutations in the NF...
Neurofibromatosis type 1 (NF 1 ) is one of dm most common autosomal dominant conditions in humans (...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder caused by mutations in the NF...
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder caused by mutations in the NF...
Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis o...
Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis o...
More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in ...
Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis o...
Neurofibromatosis type 1 (NF1) is a common familial tumour syndrome with multiple clinical features ...
Neurofibromatosis type-1 (NF1) is caused by constitutional mutations of the NF1 tumor-suppressor g...
Neurofibromatosis type-1 (NF1) is caused by constitutional mutations of the NF1 tumor-suppressor g...
More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in ...